Report cover image

Herpes Simplex Virus Treatment Market - By Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir), Site (Oral, Genital), Route of Administration (Oral, Topical), Distribution Channel (Hospital, Retail), Global Forecast, 2023-2032

Publisher Global Market Insights
Published Nov 23, 2023
Length 220 Pages
SKU # GMI18399592

Description

Herpes Simplex Virus Treatment Market - By Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir), Site (Oral, Genital), Route of Administration (Oral, Topical), Distribution Channel (Hospital, Retail), Global Forecast, 2023-2032


The global Herpes Simplex Virus (HSV) treatment market is expected to register a 4% growth rate during 2023-2032, propelled by advancements in therapeutic approaches, rising awareness about herpes infections, and a growing prevalence of Herpes Simplex Virus-2 (HSV-2).

As per a WHO report in 2023, about 67% of the global population aged below 50 years (3.7 billion) have herpes simplex virus type 1 (HSV-1), causing oral herpes. An estimated 13% of people aged 15-49 years (491 million) has herpes simplex virus type 2 (HSV-2), leading to genital herpes. Many HSV infections are asymptomatic or go unrecognized. As public awareness builds overtime, individuals are becoming more informed about the nature, transmission, and potential complications associated with herpes viruses. The focus on early diagnosis and appropriate treatments is contributing to the demand for advanced therapeutic solutions.

The global Herpes Simplex Virus (HSV) treatment industry is classified based on virus type, drug type, site, route of administration, distribution channel, and region.

The HSV-2 virus type segment is expected to witness sustained growth during the study period driven by its rising prevalence amongst the global population. There is a surge in R&D activities focused on addressing the specific challenges posed by HSV-2, emphasizing the need for specialized treatment options catering to the unique characteristics of this herpes strain.

The valacyclovir drug type segment is set for steady growth through 2032 owing to its efficacy in managing herpes infections by inhibiting viral replication. As a prodrug of acyclovir, valacyclovir enhances bioavailability and ensures prolonged antiviral activity, thereby curbing the infection. Moreover, the drug is effective against both HSV-1 and HSV-2, making it a preferred choice for clinicians and patients alike.

Asia Pacific Herpes Simplex Virus (HSV) treatment market size is anticipated to witness rapid expansion over 2023-2032, driven by a surge in the prevalence of herpes infections, necessitating increased attention to treatment and management strategies. Countries like China and India are experiencing notable advancements in healthcare infrastructure. Also, there is a growing awareness of sexually transmitted infections, contributing to the demand for effective herpes treatment solutions. The favourable healthcare policies in the region will shape the industry dynamics in the coming years.

Table of Contents

220 Pages
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Herpes simplex virus treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Virus type trends
2.1.4 Drug type trends
2.1.5 Site trends
2.1.6 Route of administration trends
2.1.7 Distribution channel trends
Chapter 3 Herpes Simplex Virus Treatment Market Insights
3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of herpes infection
3.2.1.2 Rising research and development
3.2.1.3 Increasing government funding and awareness
3.2.2 Industry pitfalls & challenges
3.2.2.1 Increasing product recalls
3.2.2.2 Unavailability of vaccines
3.3 Growth potential analysis
3.3.1 By virus type
3.3.2 By drug type
3.3.3 By site
3.3.4 By route of administration
3.3.5 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard, 2022
Chapter 5 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Virus Type, 2018-2032 (USD Million)
5.1 Key trends, by virus type
5.2 Herpes simplex virus 1
5.3 Herpes simplex virus 2
Chapter 6 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Drug Type, 2018-2032 (USD Million)
6.1 Key trends, by drug type
6.2 Acyclovir
6.3 Valacyclovir
6.4 Famciclovir
6.5 Other drug types
Chapter 7 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Site, 2018-2032 (USD Million)
7.1 Key trends, by site
7.2 Oral
7.3 Genital
7.4 Other sites
Chapter 8 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Route of Administration, 2018-2032 (USD Million)
8.1 Key trends, by route of administration
8.2 Oral
8.3 Injectable
8.4 Topical
Chapter 9 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)
9.1 Key trends, by distribution channel
9.2 Hospital pharmacy
9.3 Retail pharmacy
9.4 Online pharmacy
Chapter 10 Herpes Simplex Virus Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 GlaxoSmithKline plc
11.2 Pfizer Inc
11.3 Teva Pharmaceutical Industries Ltd
11.4 Glenmark Pharmaceuticals Limited
11.5 Amneal Pharmaceuticals LLC
11.6 Novartis AG
11.7 Abbott Laboratories
11.8 Fresenius Kabi AG
11.9 Emcure Pharmaceuticals Ltd
11.10 Viatris Inc.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us